Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydromorphone OROS for Cancer Pain Management
NCT01006356Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Oct 2008
- Primary completion
- Aug 2009
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of hydromorphone in cancer pain, sponsored by Janssen Pharmaceutical. Started Oct 2008; status: completed.
02
Drugs
hydromorphone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT01006356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01006356.